Clinical trials
Phase 2 Thyroid Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 5 |
| Terminated | 3 |
| Unknown status | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 3 |
| MBX Biosciences | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| Allergan | 1 |
| Asan Medical Center | 1 |
| Eli Lilly and Company | 1 |
| Grupo Espanol de Tumores Neuroendocrinos | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Karo Bio AB | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Diseases | 23 |
| Thyroid Neoplasms | 5 |
| Graves Disease | 2 |
| Graves Ophthalmopathy | 2 |
| Hyperthyroidism | 2 |
| Hypoparathyroidism | 2 |
| Hypothyroidism | 2 |
| Neoplasms | 2 |
| Adenocarcinoma, Follicular | 1 |
| Adenolymphoma | 1 |
Trials
Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.